Martin Luther King Jr. Community Hospital, also known as MLK-LA, is a 131-bed public community hospital in the Willowbrook neighborhood of southern Los Angeles County, California.

There are 131 beds in Martin Luther King Jr Gen Hosp / UCLA Med Ctr.

During the past decade, Martin Luther King Jr Gen Hosp / UCLA Med Ctr conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Martin Luther King Jr Gen Hosp / UCLA Med Ctr" are "HIV Infections" (2 trials). Many other conditions were trialed in "Martin Luther King Jr Gen Hosp / UCLA Med Ctr" in a lesser frequency.

Most popular intervention types in "Martin Luther King Jr Gen Hosp / UCLA Med Ctr" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (2 trials) and "Globulin, Immune" (1 trials). Other intervention names were less common.

The vast majority of trials in "Martin Luther King Jr Gen Hosp / UCLA Med Ctr" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Martin Luther King Jr Gen Hosp / UCLA Med Ctr". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Martin Luther King Jr Gen Hosp / UCLA Med Ctr, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Martin Luther King Jr Gen Hosp / UCLA Med Ctr, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".